Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0045 | 0.3875 | 0.3875 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0038 | 0.2613 | 0.7399 |
Trichomonas vaginalis | chromobox protein, putative | 0.0068 | 0.839 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.7197 | 0.5423 |
Trichomonas vaginalis | chromobox protein, putative | 0.0041 | 0.3173 | 0.3419 |
Echinococcus granulosus | tar DNA binding protein | 0.0062 | 0.7197 | 0.5423 |
Toxoplasma gondii | hypothetical protein | 0.0026 | 0.0328 | 0.0328 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0041 | 0.3173 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.1021 | 0.1021 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 CLPP1 (ENDOPEPTIDASE CLP) | 0.005 | 0.4916 | 0.4744 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 1 ClpP1 (endopeptidase CLP) | 0.005 | 0.4916 | 0.5 |
Brugia malayi | RNA binding protein | 0.0062 | 0.7197 | 0.7197 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.2613 | 0.2613 |
Echinococcus multilocularis | chromobox protein 1 | 0.0068 | 0.839 | 0.7372 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.7197 | 0.5423 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0038 | 0.2613 | 0.2714 |
Loa Loa (eye worm) | heterochromatin protein 1 | 0.0068 | 0.839 | 0.839 |
Schistosoma mansoni | chromobox protein | 0.0068 | 0.839 | 0.7372 |
Plasmodium falciparum | ATP-dependent Clp protease proteolytic subunit | 0.0026 | 0.0328 | 0.0328 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0062 | 0.7197 | 0.7197 |
Plasmodium vivax | ATP-dependent Clp protease proteolytic subunit, putative | 0.0026 | 0.0328 | 0.0328 |
Loa Loa (eye worm) | RNA binding protein | 0.0062 | 0.7197 | 0.7197 |
Brugia malayi | chromobox protein homolog 3 | 0.0038 | 0.2613 | 0.2613 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.7197 | 0.5423 |
Echinococcus multilocularis | tar DNA binding protein | 0.0062 | 0.7197 | 0.5423 |
Trichomonas vaginalis | chromobox protein, putative | 0.0068 | 0.839 | 1 |
Echinococcus multilocularis | chromobox protein 1 | 0.0068 | 0.839 | 0.7372 |
Schistosoma mansoni | chromobox protein | 0.0068 | 0.839 | 0.7372 |
Echinococcus granulosus | chromobox protein 1 | 0.0068 | 0.839 | 0.7372 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0038 | 0.2613 | 0.2714 |
Brugia malayi | TAR-binding protein | 0.0062 | 0.7197 | 0.7197 |
Echinococcus multilocularis | peptidase Clp (S14 family) | 0.005 | 0.4916 | 0.17 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.7197 | 0.5423 |
Echinococcus granulosus | chromobox protein 1 | 0.0068 | 0.839 | 0.7372 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 2 ClpP2 (endopeptidase CLP 2) | 0.005 | 0.4916 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0062 | 0.7197 | 0.7197 |
Echinococcus granulosus | peptidase Clp S14 family | 0.005 | 0.4916 | 0.17 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.7197 | 0.5423 |
Trichomonas vaginalis | chromobox protein, putative | 0.0041 | 0.3173 | 0.3419 |
Brugia malayi | Heterochromatin protein 1 | 0.0068 | 0.839 | 0.839 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0045 | 0.3875 | 0.3875 |
Loa Loa (eye worm) | TAR-binding protein | 0.0062 | 0.7197 | 0.7197 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 26.8545 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | = 44.6684 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 125.8925 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540273] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.